搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
FiercePharma
7 小时
ASH: AstraZeneca proposes fixed-duration Calquence combos in chronic lymphocytic leukemia
Trying to break from the decade-old practice of using BTK inhibitors indefinitely to treat blood cancer, AstraZeneca has ...
3 天
on MSN
FDA approves AstraZeneca's Imfinzi for limited-stage small cell lung cancer
The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
FiercePharma
3 天
AstraZeneca scores FDA nod for Imfinzi as first immunotherapy for limited-stage small cell ...
AstraZeneca has picked off another label expansion for its cancer blockbuster Imfinzi (durvalumab) as the FDA has ...
FierceBiotech
2 天
AstraZeneca, Daiichi share data behind Dato-DXd do-over amid 2nd bid for lung cancer approval
AstraZeneca and Daiichi Sankyo have shared the data they believe can secure approval for datopotamab deruxtecan (Dato-DXd) at ...
腾讯网
2 天
40年来重大突破!阿斯利康重磅免疫疗法再获FDA批准
▎药明康德内容团队编辑阿斯利康(AstraZeneca)今日宣布其重磅PD-L1抑制剂Imfinzi(durvalumab)已获得美国FDA的批准,用于治疗接受铂类同步放化疗(cCRT)后病情未进展的局限期小细胞肺癌(LS-SCLC)成人患者。小细胞 ...
3 天
AstraZeneca: FDA Approves Imfinzi To Treat Adult Patients With Limited-stage Small Cell ...
British drug maker AstraZeneca Plc (AZN.L, AZN) announced Thursday that the U.S. Food and Drug Administration has approved Imfinzi ...
来自MSN
3 天
AstraZeneca's Imfinzi Gets FDA Nod for Expanded Use in SCLC
AstraZeneca AZN announced that the FDA has approved its blockbuster cancer drug Imfinzi (durvalumab) for treating ...
Pharmabiz
2 天
AstraZeneca’s Imfinzi receives US FDA approval to treat patients with limited-stage small ...
AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following ...
3 天
FDA approves AstraZeneca’s Imfinzi to treat LS-SCLC
The US Food and Drug Administration (FDA) has approved AstraZeneca's human monoclonal antibody, Imfinzi (durvalumab), to ...
3 天
FDA Approves AstraZeneca's Blockbuster Cancer Drug Imfinzi For Aggressive Form Of Lung Cancer
Imfinzi (durvalumab) for adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed ...
3 天
AstraZeneca’s Imfinzi approved in U.S. as immunotherapy regimen for LS-SCLC
Imfinzi has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer, LS-SCLC ...
Medscape
2 天
FDA Approves Durvalumab for Limited-Stage SCLC
Durvalumab was associated with a 27% reduction in the risk for death compared with placebo in the phase 3 ADRIATIC trial.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈